Clinical Lab Chains
•31 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (31)
| Company | Market Cap | Price |
|---|---|---|
|
LH
Labcorp Holdings Inc.
Labcorp operates a network of clinical laboratories delivering diagnostic testing services.
|
$21.74B |
$248.18
-4.43%
|
|
DGX
Quest Diagnostics Incorporated
Quest Diagnostics operates a nationwide network of clinical labs, i.e., clinical lab chains delivering diagnostic testing services.
|
$19.94B |
$174.74
-1.99%
|
|
TEM
Tempus AI, Inc.
Clinical Lab Chains – Tempus operates clinical laboratories delivering sequencing-based diagnostics, expanded by the Ambry Genetics acquisition.
|
$14.99B |
$88.86
+2.63%
|
|
EXAS
Exact Sciences Corporation
The company operates clinical laboratory testing capabilities as part of delivering its diagnostic products and services.
|
$11.94B |
$62.73
-0.91%
|
|
HIMS
Hims & Hers Health, Inc.
Clinical laboratory chains / lab testing services through Trybe Labs.
|
$10.55B |
$46.65
-1.01%
|
|
DVA
DaVita Inc.
DaVita operates clinical laboratory testing facilities and diagnostic services as part of its dialysis and kidney care offerings.
|
$9.79B |
$126.52
-2.38%
|
|
GH
Guardant Health, Inc.
Clinical Lab Chains: Guardant operates CLIA-certified lab operations to process tests.
|
$8.62B |
$72.56
+4.28%
|
|
SHC
Sotera Health Company
Nelson Labs operates clinical lab testing facilities, i.e., lab chains, as part of its testing services.
|
$4.70B |
$16.58
+0.12%
|
|
WGS
GeneDx Holdings Corp.
Clinical lab chains providing genetic testing services.
|
$3.92B |
$131.76
-4.15%
|
|
GRAL
GRAIL, Inc.
Company operates clinical laboratory testing capabilities to run Galleri and related studies.
|
$3.11B |
$85.02
-1.55%
|
|
CON
Concentra Group Holdings Parent, Inc.
The business provides diagnostic testing via its clinics, aligning with laboratory testing and diagnostic service capabilities.
|
$2.65B |
$20.11
-2.78%
|
|
ADPT
Adaptive Biotechnologies Corporation
Partnership activity with NeoGenomics reflects ADPT's role in clinical lab testing services / lab chains.
|
$2.57B |
$16.80
-0.59%
|
|
QDEL
QuidelOrtho Corporation
Clinical lab chains/diagnostic service networks align with QuidelOrtho’s lab-based business model and scale.
|
$1.91B |
$27.93
-0.92%
|
|
AZTA
Azenta, Inc.
Genewiz operates as a clinical lab network, aligning with Clinical Lab Chains.
|
$1.44B |
$29.76
-5.12%
|
|
NEOG
Neogen Corporation
Genomics services and diagnostic testing capabilities may be organized or delivered through clinical lab networks, aligning with Clinical Lab Chains.
|
$1.34B |
$6.24
+1.30%
|
|
NEO
NeoGenomics, Inc.
NeoGenomics operates a network of cancer-focused testing laboratories, i.e., clinical lab chains.
|
$1.28B |
$10.29
+3.73%
|
|
CDNA
CareDx, Inc
Operates as Clinical Lab Chains or core laboratory testing facilities providing diagnostic services.
|
$816.83M |
$14.27
-2.73%
|
|
MYGN
Myriad Genetics, Inc.
Clinical lab chains—multiplicity of testing locations and labs enabling national testing services.
|
$749.40M |
$7.90
-2.83%
|
|
FLGT
Fulgent Genetics, Inc.
Company operates clinical lab chains providing diagnostic testing.
|
$713.29M |
$22.70
-3.09%
|
|
SOPH
SOPHiA GENETICS S.A.
Clinical Lab Chains: target customers include clinical laboratories and networks leveraging the platform.
|
$271.73M |
$4.56
+11.49%
|
|
XGN
Exagen Inc.
Exagen’s core diagnostic testing capability places it within clinical lab chains as a diagnostic testing provider.
|
$214.05M |
$11.85
-0.34%
|
|
BNR
Burning Rock Biotech Limited
Operates clinical laboratory testing facilities (central lab/in-hospital model).
|
$126.56M |
$12.27
+0.08%
|
|
AKYA
Akoya Biosciences, Inc.
Clinical lab chains alignment with the company’s lab services and clinical testing offerings.
|
$64.26M |
$1.29
|
|
PRPO
Precipio, Inc.
Pathology/clinical lab services and diagnostic testing operations.
|
$31.75M |
$21.25
+1.19%
|
|
CDIX
Cardiff Lexington Corporation
Nova Ortho & Spine provides diagnostic and related assessment services, aligning with Diagnostics & Lab Services in Healthcare.
|
$29.52M |
$1.50
|
|
APM
Aptorum Group Limited
Diagnostics platform potentially operating as a network of clinical labs; reflects lab-based service delivery.
|
$8.10M |
$1.47
-1.01%
|
|
TRIB
Trinity Biotech plc
Operates Immco NYSDOH-certified clinical laboratory for diagnostic testing.
|
$7.67M |
$1.01
+1.01%
|
|
BNGO
Bionano Genomics, Inc.
BNGO has historically operated Clinical Lab Chains as part of its diagnostic services portfolio.
|
$6.29M |
$1.82
-2.67%
|
|
POAI
Predictive Oncology Inc.
CLIA-certified wet-lab operations and clinical-lab-style testing/validation services.
|
$5.77M |
$8.77
-9.49%
|
|
DFCO
Dalrada Financial Corporation
Boost Diagnostics provides diagnostic testing capabilities, consistent with clinical lab chains.
|
$3.36M |
$0.04
|
|
BIAF
bioAffinity Technologies, Inc.
The company operates clinical laboratory testing facilities as part of CyPath Lung, aligning with 'Clinical Lab Chains'.
|
$2.26M |
$2.46
-1.00%
|
Loading company comparison...
Loading industry trends...
Loading research report...
